Masami Iijima
Director · TAKEDA PHARMACEUTICAL CO LTD
Individual
- 2026
- Jul 6, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Masami Iijima files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Stewart Plump - $5.34M in TAK purchases and sales in the last 12 months
- Julie So-Young Kim - $1.52M in TAK purchases and sales in the last 12 months
- Lauren Rusckowski Duprey - $1.45M in TAK purchases and sales in the last 12 months
- Nicola Deidre Petal Greenway - $957K in TAK purchases and sales in the last 12 months
- Teresa Marie Bitetti - $855K in TAK purchases and sales in the last 12 months
- Giles Richard Platford - $532K in TAK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Masami Iijima?
Masami Iijima is a corporate insider, tracked as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Masami Iijima last file a Form 4?
The only primary Form 4 on record is dated 6 July 2026.
